PARTIAL EPILEPSY

Clinical trials for PARTIAL EPILEPSY explained in plain language.

Never miss a new study

Get alerted when new PARTIAL EPILEPSY trials appear

Sign up with your email to follow new studies for PARTIAL EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 2

New hope for kids with focal seizures: cenobamate trial underway

Disease control Ongoing

This phase 3 trial is testing the safety and tolerability of the drug cenobamate (Xcopri) in 140 children aged 2 to 17 with partial-onset (focal) seizures. Researchers will monitor side effects, lab results, and drug levels in the blood. The study is open-label, meaning everyone …

Matched conditions: PARTIAL EPILEPSY

Phase: PHASE3 • Sponsor: SK Life Science, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

PARTIAL EPILEPSY

Get alerted when new PARTIAL EPILEPSY trials appear

New hope for kids with focal seizures: cenobamate trial underway